Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Utilization of depot neuroleptic medication in psychiatric inpatients.

Citrome L, Levine J, Allingham B.

Psychopharmacol Bull. 1996;32(3):321-6.

PMID:
8961774
2.

Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.

Citrome L, Jaffe A, Levine J.

Schizophr Res. 2010 Jun;119(1-3):153-9. doi: 10.1016/j.schres.2010.02.1066. Epub 2010 Mar 26.

PMID:
20347267
3.

Social aspects of therapy with depot neuroleptics in the Federal Republic of Germany.

Haring C, Tegeler J, Lehmann E, Ptock WD.

Acta Psychiatr Belg. 1981 Mar-Apr;81(2):189-202.

PMID:
6117189
4.
5.

Depot antipsychotics. Patient characteristics and prescribing pattern.

Al-Sughayir MA.

Saudi Med J. 2000 Dec;21(12):1178-81.

PMID:
11360095
6.

[Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].

Grolleau A, Cougnard A, Parrot M, Kalmi E, Desage A, Misdrahi D, Brun-Rousseau H, Verdoux H.

Encephale. 2007 May-Jun;33(3 Pt 1):326-31. French.

PMID:
17675930
7.

[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].

Bret P, Bret MC, Queuille E.

Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7. French.

PMID:
19393381
8.

A 15-year open study on a cohort of West-African out-patients with a chronic psychosis.

de Jong JT, Komproe IH.

Soc Psychiatry Psychiatr Epidemiol. 2006 Nov;41(11):897-903. Epub 2006 Sep 8.

PMID:
16964449
9.

Antipsychotic medication coprescribing in a large state hospital system.

Jaffe AB, Levine J.

Pharmacoepidemiol Drug Saf. 2003 Jan-Feb;12(1):41-8.

PMID:
12616846
10.

Use of haloperidol decanoate in psychiatric diseases.

Zonda T, Kövári E.

Ther Hung. 1992;40(2):64-8.

PMID:
1361081
11.

The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.

Dencker SJ.

J Clin Psychiatry. 1984 May;45(5 Pt 2):22-7.

PMID:
6143744
12.

Assessment and treatment selection for "revolving door" inpatients with schizophrenia.

Weiden P, Glazer W.

Psychiatr Q. 1997 Winter;68(4):377-92.

PMID:
9355136
13.

Adherence assessments and the use of depot antipsychotics in patients with schizophrenia.

Valenstein M, Copeland LA, Owen R, Blow FC, Visnic S.

J Clin Psychiatry. 2001 Jul;62(7):545-51.

PMID:
11488366
14.

Excessive antipsychotic dosing in 2 U.S. State hospitals.

Diaz FJ, De Leon J.

J Clin Psychiatry. 2002 Nov;63(11):998-1003.

PMID:
12444813
15.

A naturalistic study of risperidone treatment outcome using prognosis-adjusted discharge rates in New York State inpatients.

Javitt DC, Cienfuegos A, Miniati M, Silipo G, Levine J, Allingham BH, Robinson J.

J Clin Psychiatry. 2002 Jul;63(7):585-90.

PMID:
12143914
16.

[Evaluation of the efficacy of haloperidol decanoate in the treatment of chronic psychotic hospital patients].

Marchant N, Caruso S, Cuervo L, Brizuela A.

Acta Psiquiatr Psicol Am Lat. 1985 Mar;31(1):37-41. Spanish.

PMID:
2864788
17.

Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.

Altamura AC, Sassella F, Santini A, Montresor C, Fumagalli S, Mundo E.

Drugs. 2003;63(5):493-512. Review.

PMID:
12600227
19.
20.

Supplemental Content

Support Center